How were (HPTX)'s earnings last quarter?

(HPTX) (NASDAQ:HPTX) announced its quarterly earnings results on Thursday, February, 26th. The biopharmaceutical company reported $0.47 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.20) by $0.67. The biopharmaceutical company had revenue of $30.80 million for the quarter, compared to analyst estimates of $24.60 million. The firm's revenue for the quarter was up 65.6% on a year-over-year basis.

What other stocks do shareholders of (HPTX) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (HPTX) investors own include Tivity Health (TVTY) , Bausch Health Companies (BHC) , Berkshire Hills Bancorp (BHLB) , Cognex (CGNX) , The Cigna Group (CI) , Cynosure (CYNO) , Depomed (DEPO) , Health Net (HNT) , Infinity Pharmaceuticals (INFI) and Keryx Biopharmaceuticals (KERX) .

NASDAQ:HPTX

(HPTX) (HPTX) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free HPTX Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: 786,899 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get (HPTX) alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About (HPTX) Stock (NASDAQ:HPTX)

Horizon Therapeutics, Inc., formerly Hyperion Therapeutics, Inc., is a biopharmaceutical company. The Company is engaged in the development and commercialization of therapeutics to treat disorders in the areas of orphan diseases. The Company's products include RAVICTI (glycerol phenylbutyrate) oral liquid, BUPHENYL and AMMONAPS (sodium phenylbutyrate) tablets and powder. The Company's products are used to lower ammonia in the blood. RAVICTI is used to treat urea cycle disorders (UCD). BUPHENYL is indicated as an adjunctive therapy in the chronic management of patients with UCDs involving deficiencies of carbamylphosphate synthetase (CPS), ornithine transcarbamylase (OTC), or argininosuccinic acid synthetase (AS). The Company sells BUPHENYL under the brand name AMMONAPS in Europe and the Middle East.

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

HPTX Stock News Headlines

April 10, 2024 | bbc.co.uk

Nigel Clough: "The manner of the performance is what pleased us most"

April 10, 2024 | bbc.co.uk

Nigel Clough: "The manner of the performance is what pleased us most"

April 20, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

February 6, 2024 | msn.com

Professional Faqs: How I Reversed My Hashimoto's Disease Naturally?

February 5, 2024 | msn.com

Buc-ee's in Mebane: City leaders to discuss traffic impacts Monday night

January 29, 2024 | msn.com

Power cuts in Bengaluru till end of the month; Check areas list, timings

October 7, 2023 | msn.com

Ten Hag praises Mason Mount's contribution since returning from injury

September 30, 2023 | msn.com

William Blount’s 1797 impeachment trial set precedent for future cases

April 20, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

September 30, 2023 | msn.com

The laws about falsifying your address to get into a better school in your state

September 28, 2023 | msn.com

Packers injury update puts David Bakhtiari in doubt for longer than expected

September 28, 2023 | msn.com

Hammer of Thor! Son Kicks to Death Elderly Dad, Tells Cops He Wanted to Reach ‘Valhalla’

March 30, 2023 | msn.com

ESA confirms cancellation of E3 2023

March 30, 2023 | msn.com

Punjab cops using drone to hunt Amritpal

March 30, 2023 | msn.com

Mississippi State baseball score vs. South Carolina: Live updates from Dudy Noble Field

February 9, 2023 | msn.com

A 21-year-old who says she never got 'bad' sunburn or used a tanning bed was diagnosed with the deadliest type of skin cancer

January 24, 2023 | msn.com

Brawlhalla reveals Battle Pass 7 release date, new Mode and more

January 12, 2023 | msn.com

Teenager arrested over shooting death of another teen in Central Lubbock, LPD said

December 27, 2022 | msn.com

'Lampard looked physically ill' - National media make same blunt Everton point after Wolves defeat

August 30, 2022 | msn.com

Report: Forest could end transfer window with a bang as Marinakis eyes blockbuster £43m player

November 27, 2021 | msn.com

Save a huge 47% off on this top-ranked EVGA 500W PSU for your ATX PC build

November 2, 2021 | msn.com

Dallas Area Weekday Events: Check Out What's Happening

September 25, 2021 | msn.com

These Are the 12 Best Picnic Spots in Dallas

September 7, 2021 | msn.com

This Week's Dallas Area Events

See More Headlines

Receive HPTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (HPTX) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/26/2015
Today: 4/20/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: N/A
Industry: N/A
Sub-Industry: Biotechnology
Current Symbol: NASDAQ:HPTX
CUSIP: 44915N10
CIK: 1386858
Web: N/A
Phone: +1-650-7457802
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

HPTX Stock Analysis - Frequently Asked Questions

How were (HPTX)'s earnings last quarter?: (HPTX) (NASDAQ:HPTX) announced its quarterly earnings results on Thursday, February, 26th. The biopharmaceutical company reported $0.47 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.20) by $0.67. The biopharmaceutical company had revenue of $30.80 million for the quarter, compared to analyst estimates of $24.60 million. The firm's revenue for the quarter was up 65.6% on a year-over-year basis.
What other stocks do shareholders of (HPTX) own?: Based on aggregate information from My MarketBeat watchlists, some companies that other (HPTX) investors own include Tivity Health (TVTY), Bausch Health Companies (BHC), Berkshire Hills Bancorp (BHLB), Cognex (CGNX), The Cigna Group (CI), Cynosure (CYNO), Depomed (DEPO), Health Net (HNT), Infinity Pharmaceuticals (INFI) and Keryx Biopharmaceuticals (KERX).

This page (NASDAQ:HPTX) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

(HPTX) (HPTX) Stock Price, News & Analysis

About (HPTX) Stock (NASDAQ:HPTX)

HPTX Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

HPTX Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info